Home > Insider Trading > Filing (0001179110-19-007733)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1597264	Blueprint Medicines Corp	BPMC	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1769740	Ariel Hurley	C/O Blueprint Medicines Corporation 45 Sidney Street Cambridge MA 02139	Principal Accounting Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2019-06-12	243	$85.00	0	No	4	S	Direct
Common Stock	Acquisiton	2019-06-12	830	$1.87	830	No	4	M	Direct
Common Stock	Disposition	2019-06-12	830	$85.00	0	No	4	S	Direct
Common Stock	Acquisiton	2019-06-13	1,660	$1.87	1,660	No	4	M	Direct
Common Stock	Disposition	2019-06-13	1,660	$90.00	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2019-06-12	830	$0.00	830	$1.87
Common Stock	Stock Option (Right to Buy)	Disposition	2019-06-13	1,660	$0.00	1,660	$1.87

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
16,749		2024-10-08	No	4	M	Direct
15,089		2014-10-08	No	4	M	Direct

Footnotes

Effected pursuant to a trading plan adopted on December 17, 2018 pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
Consists of 243 shares that were acquired under the Issuer's employee stock purchase plan on May 31, 2019.
This option was granted on October 8, 2014. This option vested with respect to 25% of the shares underlying the option on September 15, 2015 and vested as to an additional 1/48th of the shares underlying the option each month thereafter.